David Klein

David Benshoof Klein is a healthcare investor and entrepreneur with over 19 years of experience in the life science industry.

He is the co-founder and CEO of Click Therapeutics, a company focused on developing and commercializing software as medical treatments known as Digital Therapeutics™.

Under his leadership, Click Therapeutics has successfully launched innovative programs for smoking cessation and is progressing a diverse pipeline of prescription Digital Therapeutics for various high-burden therapeutic areas.

David Klein has a background in founding, financing, and operating more than 10 life science companies, showcasing his expertise and leadership in the industry.

Prior to Click Therapeutics, he held key roles as the Managing Director at Opus Point Partners, a senior consultant at Pfizer, and as a strategic advisor to numerous public and privately held life science companies.

He is also recognized for his contributions to academia, having been a guest lecturer at prestigious institutions like Columbia University's Biotechnology Program, Columbia Business School, and NYU Stern School of Business.

David Klein holds a B.A. from Brandeis University and was acknowledged by Goldman Sachs in 2019 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference.

Outside of his professional endeavors, Mr. Klein is an art enthusiast and co-founder and owner of Eli Klein Gallery, a prominent Chinese contemporary art gallery with locations in New York's Chelsea art district and Beijing, China.